Want to see JP:4884 full AI Analyst Report?
Kringle Pharma, Inc. (4884) Drug Pipeline
| Drug Name | Condition | Stage | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Kp-100Li | Vocal Fold Scar | Phase III | Recruiting | Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar | Nov 16, 2022 | ― |
| Drug Name | Stage | Condition | Status | Study Name | Trial Start Date | Article |
|---|---|---|---|---|---|---|
| Kp-100Li | Phase III | Vocal Fold Scar | Recruiting | Phase 3 Study of KP-100LI in Subjects With Vocal Fold Scar | Nov 16, 2022 | ― |
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Kringle Pharma, Inc. (JP:4884) have in its pipeline
Kringle Pharma, Inc. JP:4884 is currently developing the following drugs: Kp-100Li. These drug candidates are in various stages of clinical development as the company works toward FDA approval.